Transfusion service red blood cell reagents

Ended Awarded Last action

Contract number
36C24626N0320
Awardee
Awarding agency
Obligated
$18,025

Award facts

Contract value 100% obligated
$18,024.94 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Raritan, NJ 08869, USA

Award details come from SAM.gov/FPDS.

About this award

Veterans Integrated Service Network 6 issued a BPA call to Ortho-Clinical Diagnostics, Inc. for transfusion service red blood cell reagents valued at $18,024.94, with an award date of October 1, 2025 and ultimate completion date of September 30, 2026. The awardee is a HUBZone joint venture. Place of performance is Raritan, New Jersey. The call was issued under firm fixed price terms with no set-aside designation.

Quick answers

Who was awarded contract 36C24626N0320?

36C24626N0320 was awarded to Ortho-Clinical Diagnostics, Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on October 1, 2025.

How much is contract 36C24626N0320 worth?

The government has obligated $18,025 on 36C24626N0320.

Is contract 36C24626N0320 an order under another contract?

Yes. 36C24626N0320 is a BPA call under 36C24624A0001, a blanket purchase agreement.

Was contract 36C24626N0320 competed?

The extent of competition for 36C24626N0320 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award